Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
32 | 59 | 77 | 13 | 11 |
Year wise citations received |
172 | 256 | 226 | 169 | 197 |
Journal total citations count | 1776 |
Journal impact factor | 5.32 |
Journal 5 years impact factor | 5.62 |
Journal cite score | 5.3 |
Journal h-index | 22 |
Journal h-index since 2018 | 17 |
Important citations (1101)
Subtractive genomics approach in identifying polysacharide biosynthesis protein as novel drug target against eubacterium nodatum |
|
Subtractive genomics approach towards the identification of novel therapeutic targets against human bartonella bacilliformis |
|
A review on various aspects of hiv infection |
|
Anti-nipah: a qsar based prediction method to identify the inhibitors against nipah virus |
|
Knowledge, awareness, attitude, and practice of health-care professionals toward hepatitis b disease and vaccination in saudi arabia |
|
Practices of patients consuming antibiotics and knowledge about antibiotic resistance in hail region – saudi arabia |
|
Development and validation of a simple and sensitive hplc method for the determination of liquid form of therapeutic substances |
|
Natural compounds against flaviviral infections |
|
Antiviral activity of agarwood aquilaria malaccensis lamk and gyrinops versteegii (gilg.) domke leaves ethanolic extract against dengue serotype 3 virus in vitro |
|
A systematic review on phytochemicals for the treatment of dengue |
|
Mini review on dengue fever |
|
Influenza “trains” the host for enhanced susceptibility to secondary bacterial infection |
|
Serum high-mobility-group box 1 as a biomarker and a therapeutic target during respiratory virus infections |
|
Rhinovirus biology, antigenic diversity, and advancements in the design of a human rhinovirus vaccine |
|
Syrian hamster as an animal model for the study of human influenza virus infection |
|
Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of h1n1pdm virus |
|
Maternal immunization with a recombinant adenovirus-expressing fusion protein protects neonatal cotton rats from respiratory syncytia virus infection by transferring antibodies via breast milk and placenta |
|
Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of h1n1pdm virus |
|
Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: effects of low vaccine dose and single vs booster vaccination |
|
Targeting tlr4 signaling to blunt viral-mediated acute lung injury |
|